
Gennady Bratslavsky MD
Professor and Chair of Urology Division Chief of Upstate Urology at 550 Harrison Division Chief of Urologic Male Health Director of Prostate Cancer Program Department Chief of Adult Urology Clinic Department Chief of Urologic Oncology SUNY Upstate Medica
Join to View Full Profile
750 E Adams StSyracuse, NY 13210
Phone+1 315-464-6106
Fax+1 315-464-6117
Dr. Bratslavsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Albany Medical CenterResidency, Urology, 2000 - 2005
- Albany Medical CollegeClass of 2000
Certifications & Licensure
- NY State Medical License 2011 - 2026
- PA State Medical License 2013 - 2018
- VA State Medical License 2005 - 2012
- American Board of Urology Urology
Clinical Trials
- Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types.Axel Bex, Michael Jewett, Bryan Lewis, E Jason Abel, Laurence Albiges
European Urology. 2025-04-01 - Primary sarcomas of the bladder and prostate: A genomic landscape study.Dana Hariri, Dean Pavlick, Phillipe Spiess, Roger Li, Ashish Kamat
Pathology, Research and Practice. 2025-03-01 - Renal Function After Partial Nephrectomy: A Comparative Analysis of Warm, Cold, and No Ischemia Methods.Sandeep Gurram, Jillian Egan, Maria Antony, Michael A Ahdoot, Nitin K Yerram
Urology Practice. 2025-02-04
Lectures
- Ductal (PDC), acinar (PAC) and neuroendocrine (PNC) carcinomas of the prostate: A comparative comprehensive genomic profiling (CGP) study.ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- Malignant pheochromocytoma (MP): A comprehensive genomic profiling (CGP) study.ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- PBRM1Â mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Join now to see all
Press Mentions
- Landmark Study in Non-Muscle Invasive Bladder Cancer Evaluating Breakthrough Investigational Gene Therapy Nadofaragene Firadenovec Published in the Lancet OncologyNovember 30th, 2020
- Upstate Professors to Present at International Cancer Conference in SpainSeptember 27th, 2019
- Cytoreductive Nephrectomy May Benefit RCC Patients with Brain MetsDecember 12th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: